• The small molecule d mannuronic acid M patented

  2020-08-03

  

  The small molecule β-d-mannuronic Ivermectin synthesis (M2000), patented (DE-102016113018.4), has been tested as an anti-inflammatory and a novel immunosuppressive agent in various experimental models such as animal models of immune complex glomerulonephritis, nephrotic syndrome, multiple sclerosis

• br Involvement of p and Sp To investigate transcriptional

  2020-08-03

  

  Involvement of p53 and Sp1 To investigate transcriptional regulation of the COX-2 gene in response to HNE, Kumagai et al. [15] examined whether the HNE-induced COX-2 expression was mechanistically linked to the expression of p53, a transcription factor that regulates the response to a variety of

• br Introduction Cardiovascular heart disease CHD is the lead

  2020-08-03

  

  Introduction Cardiovascular heart disease (CHD) is the leading cause of death worldwide [1]. One of the major risk factors for CHD are elevated serum cholesterol concentrations [2]. Lowering the level of serum cholesterol is an established clinical practice for CHD treatment, intervention, and pr

• HOIP s ability to build linear Ub

  2020-08-03

  

  HOIP\'s ability to build linear Ub chains arises from a unique domain that follows directly after the RING2 domain, the linear ubiquitin chain-determining domain (LDD) (Fig. 1). Structures have revealed that the LDD is structurally integrated into RING2, creating a single RING2–LDD unit (Fig. 2D) [4

• MuRF and MuRF are also known to have considerable

  2020-08-03

  

  MuRF2 and MuRF3 are also known to have considerable functional overlap in binding to microtubules and in sarcomere formation in the process of calcitonin gene related peptide of striated muscle cells [61]. Double knockout of MuRF1 and 3 in mice resulted in protein aggregate-associated myopathy in s

• br Acknowledgements br Introduction Hydroxy l arginine NOHA

  2020-08-03

  

  Acknowledgements Introduction -Hydroxy-l-arginine (NOHA) is an intermediate in the oxidation of l-arginine to nitric oxide (NO) catalyzed by NO-synthases (NOS) [1], [2]. In mammals, NO is an important mediator that displays key roles in the cardiovascular, nervous and immune systems [3]. NOHA

• Connexins the structural proteins of gap

  2020-08-03

  

  Connexins, the structural proteins of gap junctions, are a family of transmembrane proteins that oligomerize into hemichannels containing six connexin subunits [9]. Upon reaching the cell surface, two hemichannels pair to complete an intercellular gap junction channel, which directly links the cytop

• Our data suggest that VEGF A inhibits venous

  2020-08-03

  

  Our data suggest that VEGF-A inhibits venous identity in adult EC, recapitulating the change seen during vein graft Guanethidine Sulfate in vivo. Vein graft adaptation to the arterial environment may depend on the plasticity of adult EC, and their ability to integrate VEGF signaling pathways, to pro

• Indirubin br Materials and methods br Results In

  2020-08-03

  

  Materials and methods Results In the 4-plex iTRAQ labelled peptides, the fragments released from CID were the reporter ions at 114.1, 115.1, 116.1 and 117.1m/z. The fragmentation spectrum of f15–30 of αs1-casein is shown by way of example in Fig. 1. The sequence coverage was 56% and 60% for th

• Here we report the development of a

  2020-08-03

  

  Here we report the development of a new fluorescence intensity (FLINT), signal increase, high-throughput assay that measures the oxidation of L-DHO to -orotate by DHODH. In this reaction, the reducing equivalents from the oxidation of the L-DHO are transferred to the FMN, yielding the reduced enzyme

• br Acknowledgments We thank Jon Clardy Juan Manuel Dom

  2020-08-03

  

  Acknowledgments We thank Jon Clardy, Juan Manuel Domínguez, José Francisco García Bustos, and the GlaxoSmithKline (GSK) Plasmodium falciparum dihydroorotate dehydrogenase project team for their contributions, helpful advice, and discussions. Introduction Dihydroorotate dehydrogenase (DHODH) i

• br Disclosure statement br Acknowledgment and sources

  2020-08-01

  

  Disclosure statement Acknowledgment and sources of funding We would like to thank Dr. Brain Lau, who helped us strongly with the editing and reviewing of the manuscript. The research was funded by the Joint Council Office (JCO), Agency for Science, Technology & Research (A*STAR), Singapore.

• Different pathways activated by kinases are

  2020-07-31

  

  Different pathways activated by kinases are involved in the cardioprotective mechanisms afforded by ischemic and pharmacological interventions (Schulz et al., 2004; Heusch et al., 2008). Furthermore, it was also demonstrated that phosphorylation of eNOS by Akt with a subsequent increase in NO produc

• br Materials and methods br Results br Discussion Kaempferia

  2020-07-31

  

  Materials and methods Results Discussion Kaempferia parviflora has been long used as a herbal medicine. Methoxyflavones, which are the major components in this plant, can be used as standards for the characterization of Kaempferia parviflora extract. They can be identified and quantified by

• The canonical BCL repressive mechanism of action in GC B

  2020-07-31

  

  The canonical BCL6 repressive mechanism of action in GC wdr5 sale is mediated by recruitment of the SMRT, NCOR, and BCOR corepressors to the BCL6 BTB domain (Hatzi and Melnick, 2014). However, we find that Bcl6 BTB mutant mice are still mostly capable of forming early GC clusters. This phenotype is

15772 records 783/1052 page Previous Next First page 上5页 781782783784785 下5页 Last page